The Global Growth Hormone Deficiency market is expected to reach USD 2.1 billion with the increasing number of Growth Hormone Deficiency(GHD) cases worldwide

Hyderabad, June 20, 2019 -- The "Growth Hormone Deficiency Market : Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2026" report has been added to Datamintelligence.com's offering.
According to Boston Children’s Hospital, about one in 4,000 to 10,000 children have growth hormone deficiency in the US, and approximately 50,000 adults have a growth hormone deficiency, with about 6,000 new adult patients diagnosed every year.
Click here to get your copy of free sample https://www.datamintelligence.com/research-report/growth-hormone-deficiency-market
Growth Hormone Deficiency Market Trends : Drivers and Restraints
⦁ The market is driven by an increase in the incidences of GHD, the introduction of technologically advanced drugs with improved patient compliance and increased awareness of the disease.
⦁ Approximately 150,000 children are referred with short stature (SS) based on a cut-off of the fifth percentile. The most important endocrine and treatable cause of SS is GHD.
⦁ Technological advancements such as development of recombinant human growth hormones (rhGH) by prominent market players like Pfizer and Nova Nordisk is further expected to boost the market growth in coming years.
⦁ The high cost of treatment for GHD is the only reason that is expected to restrain the market growth over the period of forecast.
Growth Hormone Deficiency Market Segmentation:
By Treatment Type
⦁ Surgery
⦁ Growth Hormone Therapy
By End Users
⦁ Hospitals
⦁ Clinics
⦁ Homecare
By Distribution Channel
⦁ Hospital Pharmacy
⦁ Retail Pharmacy
⦁ Online Pharmacies
By Region
⦁ Asia Pacific (China, Japan, India, Australia, Rest of Asia Pacific)
⦁ Europe (Germany, France, The UK, Italy, Spain, Rest of Europe)
⦁ North America (The USA, Canada, Mexico)
⦁ South America (Brazil, Argentina, Rest of South America)
⦁ Rest of the World

Key Points covered in the report
⦁ Growth Hormone Deficiency Market – Methodology and Scope
⦁ Growth Hormone Deficiency Market – Trends
⦁ Growth Hormone Deficiency Market – Industry Analysis
⦁ Geographical Analysis
⦁ Competitive Landscape
⦁ Company Profiles

Growth Hormone Deficiency Market Key Companies
Novartis, Roche, Allergan, Hoffmann-La Roche Ltd., Regeneron Pharmaceuticals, Inc., Pfizer Inc., Bayer AG, and Bausch & Lomb Incorporated.

For more information about this report visit https://www.datamintelligence.com/research-report/growth-hormone-deficiency-market

DataM Intelligence also offers Custom Research services providing focused, comprehensive and tailored research.

1st floor, Phoenix Tech Tower, Plo no: 14/46, Habsidguda, IDA-Uppal, Hyderabad-500039, Telangana.

DataM Intelligence 4Market Research is a market intelligence platform which gives access to syndicated, customised reports to its clients at one place. As a firm with rich experience in research and consulting across multiple domains we are one stop solution that will cater to the needs of clients in key business areas.

This release was published on openPR.